These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 22348193)
1. Outcome of Antifungal Combination Therapy for Invasive Mold Infections in Hematological Patients is Independent of the Chosen Combination. Rojas R; Molina JR; Jarque I; Montes C; Serrano J; Sanz J; Besalduch J; Carreras E; Tomas JF; Madero L; Rubio D; Conde E; Sanz MA; Torres A Mediterr J Hematol Infect Dis; 2012; 4(1):e2012011. PubMed ID: 22348193 [TBL] [Abstract][Full Text] [Related]
2. Multicentre surveillance study on feasibility, safety and efficacy of antifungal combination therapy for proven or probable invasive fungal diseases in haematological patients: the SEIFEM real-life combo study. Candoni A; Caira M; Cesaro S; Busca A; Giacchino M; Fanci R; Delia M; Nosari A; Bonini A; Cattaneo C; Melillo L; Caramatti C; Milone G; Scime' R; Picardi M; Fanin R; Pagano L; Mycoses; 2014 Jun; 57(6):342-50. PubMed ID: 24373120 [TBL] [Abstract][Full Text] [Related]
3. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections. Moen MD; Lyseng-Williamson KA; Scott LJ Drugs; 2009; 69(3):361-92. PubMed ID: 19275278 [TBL] [Abstract][Full Text] [Related]
4. Real-Life Considerations on Antifungal Treatment Combinations for the Management of Invasive Mold Infections after Allogeneic Cell Transplantation. Glampedakis E; Roth R; Masouridi-Levrat S; Chalandon Y; Mamez AC; Giannotti F; Van Delden C; Neofytos D J Fungi (Basel); 2021 Sep; 7(10):. PubMed ID: 34682233 [TBL] [Abstract][Full Text] [Related]
5. Treatment of invasive fungal infections in high risk hematological patients. The outcome with liposomal amphotericin B is not negatively affected by prior administration of mold-active azoles. De la Serna J; Jarque I; López-Jiménez J; Fernández-Navarro JM; Gómez V; Jurado M; Pascual A; Serrano J; Romero M; Vallejo C Rev Esp Quimioter; 2013 Mar; 26(1):64-9. PubMed ID: 23546466 [TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis. Cesaro S; Toffolutti T; Messina C; Calore E; Alaggio R; Cusinato R; Pillon M; Zanesco L Eur J Haematol; 2004 Jul; 73(1):50-5. PubMed ID: 15182338 [TBL] [Abstract][Full Text] [Related]
7. Sequential systematic anti-mold prophylaxis with micafungin and voriconazole results in very low incidence of invasive mold infections in patients undergoing allogeneic hematopoietic stem cell transplantation. Rosillo C; Avila AM; Huang YT; Devlin S; Cho C; Montoro J; Maloy MA; Papanicolaou GA; Barba P; Perales MA Transpl Infect Dis; 2018 Aug; 20(4):e12897. PubMed ID: 29668073 [TBL] [Abstract][Full Text] [Related]
8. [Identification of filamentous fungi isolated from clinical samples by two different methods and their susceptibility results]. Direkel S; Otağ F; Aslan G; Ulger M; Emekdaş G Mikrobiyol Bul; 2012 Jan; 46(1):65-78. PubMed ID: 22399173 [TBL] [Abstract][Full Text] [Related]
9. Combination Antifungal Therapy for Invasive Mold Infections Among Pediatric Patients with Hematological Malignancies: Data from A Real-Life Case-Series. Peri AM; Verna M; Biffi S; Alagna L; Longhi B; Migliorino GM; Foresti S; Bandera A; Rovelli A; Rizzari C; Gori A; Colombini A Pathog Immun; 2019; 4(2):180-194. PubMed ID: 31538132 [TBL] [Abstract][Full Text] [Related]
10. A rescue therapy with a combination of caspofungin and liposomal amphotericin B or voriconazole in children with haematological malignancy and refractory invasive fungal infections. Yilmaz D; Balkan C; Ay Y; Akin M; Karapinar B; Kavakli K Mycoses; 2011 May; 54(3):234-42. PubMed ID: 19906090 [TBL] [Abstract][Full Text] [Related]
11. Invasive Scedosporium spp. and Lomentospora prolificans infections in pediatric patients: Analysis of 55 cases from FungiScope® and the literature. Seidel D; Hassler A; Salmanton-García J; Koehler P; Mellinghoff SC; Carlesse F; Cheng MP; Falces-Romero I; Herbrecht R; Jover Sáenz A; Klimko N; Mareş M; Lass-Flörl C; Soler-Palacín P; Wisplinghoff H; Cornely OA; Pana Z; Lehrnbecher T Int J Infect Dis; 2020 Mar; 92():114-122. PubMed ID: 31863876 [TBL] [Abstract][Full Text] [Related]
12. Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). Cornely OA; Maertens J; Bresnik M; Ebrahimi R; Ullmann AJ; Bouza E; Heussel CP; Lortholary O; Rieger C; Boehme A; Aoun M; Horst HA; Thiebaut A; Ruhnke M; Reichert D; Vianelli N; Krause SW; Olavarria E; Herbrecht R; Clin Infect Dis; 2007 May; 44(10):1289-97. PubMed ID: 17443465 [TBL] [Abstract][Full Text] [Related]
13. Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin. Aliff TB; Maslak PG; Jurcic JG; Heaney ML; Cathcart KN; Sepkowitz KA; Weiss MA Cancer; 2003 Feb; 97(4):1025-32. PubMed ID: 12569602 [TBL] [Abstract][Full Text] [Related]
14. Combination antifungal treatment for invasive fungal disease after hematopoietic stem cell transplantation in children with hematological disorders. Qiu KY; Liao XY; Fang JP; Xu HG; Li Y; Huang K; Zhou DH Transpl Infect Dis; 2019 Jun; 21(3):e13066. PubMed ID: 30859662 [TBL] [Abstract][Full Text] [Related]
15. [Treatment of invasive fungal infections with voriconazole. Evaluation of experience with compassionate use of voriconazole in Spain]. Díaz Pedroche C; Cisneros JM; Lumbreras C; Aguado JM; Rev Esp Quimioter; 2005 Jun; 18(2):149-58. PubMed ID: 16130037 [TBL] [Abstract][Full Text] [Related]